North American Scientific will showcase its ClearPath, a high-dose rate radiation treatment created for breast brachytherapy, aiming to enhance current accelerated partial breast irradiation (APBI) treatment options. The company’s multichannel catheter system, which is inserted through a single incision, is designed to allow for low-dose or high-dose therapy. ClearPath reportedly offers physicians greater flexibility in treatment planning and dose optimization to the target region, while minimizing exposure to nearby healthy tissue.
NAS Highlights Versatile Radiation Therapy System
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.